Dr Roberto Salgado
Clinical (Senior Lecturer)
The Sir Peter MacCallum Department of Oncology
545 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
Clarifying validation terminologies in healthcare
DOI: 10.1038/s41746-026-02471-22026
Journal article
Long-term outcomes and treatment response in early-stage invasive lobular carcinoma: insights from a nationwide population-based study
DOI: 10.1016/j.esmoop.2026.1077312026
Journal article
Incremental prognostic value of an AI-derived histology signature beyond the 21-gene recurrence score: A prospective-retrospective validation in TAILORx.
DOI: 10.1200/jco.2026.44.16_suppl.5542026
Journal article
Immunity, Age, and Luminal Breast Cancer: Understanding the Holy Trinity
DOI: 10.1158/1078-0432.CCR-25-40352026
Journal article
Phase II RAINSPOT: A multicentric open label trial of zolbetuximab-paclitaxel-ramucirumab in second-line setting for CLDN18.2-positive gastro-esophageal adenocarcinoma.
DOI: 10.1200/jco.2026.44.16_suppl.tps42432025
Research grants (international)
Validation and Comparison of Computational Pathology-Measured Immune-Biomarkers Using AI-and AI-foundation Models With Patient Level Outcomes in Multiple Randomized Breast Cancer Trials.
2014
Journal article
Deciphering clonality in aneuploid breast tumors using SNP array and sequencing data
DOI: 10.1186/s13059-014-0470-7
RECENT SCHOLARLY WORKS
2026
Journal article
Integrating tumor-infiltrating iymphocytes (TILs) in the biomarker landscape of gastroesophageal adenocarcinoma: Going beyond PD-L1.
DOI: 10.1200/jco.2026.44.16_suppl.40982026
Journal article
AI-based assessment of tumor-infiltrating lymphocytes (TILs) in patients with triple-negative breast cancer (TNBC) receiving neoadjuvant chemotherapy versus chemo-immunotherapy.
DOI: 10.1200/JCO.2026.44.16_suppl.e125832026
Journal article
Prognostic validation of artificial intelligence (AI)–based Stratipath breast risk stratification in TAILORx.
DOI: 10.1200/JCO.2026.44.16_suppl.5552026
Journal article
Analysis of computational tumor-infiltrating lymphocytes in breast cancer from the results of the TIGER challenge.
DOI: 10.1038/s41467-026-72956-x2026
Journal article
AI-powered and manual assessment of tumor-infiltrating lymphocytes in early HER2-positive breast cancer in NSABP B-41.
DOI: 10.1038/s41523-026-00961-w